Энергия мозга. Теория развития всех психических заболеваний, объясняющая их общую причину

19. D. Alnæs, T. Kaufmann, D. van der Meer, et al. “Brain Heterogeneity in Schizophrenia and Its Association with Polygenic Risk.” JAMA Psychiatry 76(7) (published online April 10, 2019): 739–748. doi: 10.1001/ jamapsychiatry.2019.0257.

20. J. Allen, R. Romay-Tallon, K. J. Brymer, H. J. Caruncho, and L. E. Kalynchuk. “Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.” Front Neurosci 12 (June 6, 2018): 386. doi: 10.3389/fnins.2018.00386.

21. D. Ben-Shachar and R. Karry. “Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies Between Schizophrenia, Bipolar Disorder and Major Depression.” PLoS One 3(11) (2008): e3676. doi: 10.1371/journal.pone.0003676.

22. J. Pu, Y. Liu, H. Zhang, et al. “An Integrated Meta-Analysis of Peripheral Blood Metabolites and Biological Functions in Major Depressive Disorder.” Mol Psychiatry 26 (2020): 4265–4276. doi: 10.1038/ s41380-020-0645-4.

23. C. Nasca, B. Bigio, F. S. Lee, et al. “Acetyl-L–Carnitine Deficiency in Patients with Major Depressive Disorder.” Proc Natl Acad Sci USA 115(34) (2018): 8627–8632. doi: 10.1073/pnas.1801609115.

24. Ait Tayeb, Abd El Kader, Romain Colle, Khalil El-Asmar, Kenneth Chappell, Cécile Acquaviva-Bourdain, Denis J. David, Séverine Trabado, et al. “Plasma Acetyl-L–Carnitine and L–Carnitine in Major Depressive Episodes: A Case – Control Study Before and After Treatment.” Psychol Med (2021): 1–10. doi: 10.1017/ S003329172100413X.

25. E. Gebara, O. Zanoletti, S. Ghosal, J. Grosse, B. L. Schneider, G. Knott, S. Astori, and C. Sandi. “Mitofusin-2 in the Nucleus Accumbens Regulates Anxiety and Depression-like Behaviors Through Mitochondrial and Neuronal Actions.” Biol Psychiatry 89(11) (2021): 1033–1044. doi: 10.1016/j.biopsych.2020.12.003.

26. M. D. Altschule, D. H. Henneman, P. Holliday, and R. M. Goncz. “Carbohydrate Metabolism in Brain Disease. VI. Lactate Metabolism After Infusion of Sodium d-Lactate in Manic-Depressive and Schizophrenic Psychoses.” AMA Arch Intern Med 98 (1956): 35–38. doi: 10.1001/archinte.1956.00250250041006.

27. Gerwyn Morris, Ken Walder, Sean L. McGee, Olivia M. Dean, Susannah J. Tye, Michael Maes, and Michael Berk. “A Model of the Mitochondrial Basis of Bipolar Disorder.” Neurosci Biobehav Rev 74 (2017): 1–20. doi: 10.1016/j.neubiorev.2017.01.014.

28. Anna Giménez-Palomo, Seetal Dodd, Gerard Anmella, Andre F. Carvalho, Giselli Scaini, Joao Quevedo, Isabella Pacchiarotti, Eduard Vieta, and Michael Berk. “The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.” Front Psychiatry 12 (2021): 977. doi: 10.3389/ fpsyt.2021.546801.

29. D. Wang, Z. Li, W. Liu, et al. “Differential Mitochondrial DNA Copy Number in Three Mood States of Bipolar Disorder.” BMC Psychiatry 18 (2018): 149. doi: 10.1186/s12888-018-1717-8.

30. G. Preston, F. Kirdar, and T. Kozicz. “The Role of Suboptimal Mitochondrial Function in Vulnerability to Post-traumatic Stress Disorder.” J Inherit Metab Dis 41(4) (2018): 585–596. doi: 10.1007/ s10545-018-0168-1.

31. S. Ali, M. Patel, S. Jabeen, R. K. Bailey, T. Patel, M. Shahid, W. J. Riley, and A. Arain. “Insight into Delirium.” Innov Clin Neurosci 8(10) (2011): 25–34. PMID: 22132368.

32. A. J. Slooter, D. Van, R. R. Leur, and I. J. Zaal. “Delirium in Critically Ill Patients.” Handb Clin Neurol 141 (2017): 449–466. doi: 10.1016/B978-0-444-63599-0.00025-9.

33. G. L. Engel and J. Romano. “Delirium, a Syndrome of Cerebral Insufficiency.” J Chronic Dis. 9(3) (1959): 260–277. doi: 10.1016/0021-9681(59)90165-1.

34. J. E. Wilson, M. F. Mart, C. Cunningham, et al. “Delirium.” Nat Rev Dis Primers 6 (2020): 90. doi: 10.1038/ s41572-020-00223-4.

35. L. R. Haggstrom, J. A. Nelson, E. A. Wegner, and G. A. Caplan. “2-(18)F-fluoro-2-deoxyglucose Positron Emission Tomography in Delirium.” J. Cereb. Blood Flow Metab 37(11) (2017): 3556–3567. doi: 10.1177/0271678X17701764.

36. A. J. Slooter, D. Van, R. R. Leur, and I. J. Zaal. “Delirium in Critically Ill Patients.” Handb Clin Neurol 141 (2017): 449–466. doi: 10.1016/B978-0-444-63599-0.00025-9; T. E. Goldberg, C. Chen, Y. Wang, et al. “Association of Delirium with Long-Term Cognitive Decline: A Meta-analysis.” JAMA Neurol. Published online July 13, 2020. doi: 10.1001/jamaneurol.2020.2273.

37. G. Naeije, I. Bachir, N. Gaspard, B. Legros, and T. Pepersack. “Epileptic Activities and Older People Delirium.” Geriatr Gerontol Int 14(2) (2014): 447–451. doi: 10.1111/ggi.12128.

38. Jorge I. F. Salluh, Han Wang, Eric B. Schneider, Neeraja Nagaraja, Gayane Yenokyan, Abdulla Damluji, Rodrigo B. Serafim, and Robert D. Stevens. “Outcome of Delirium in Critically Ill Patients: Systematic Review and Meta-Analysis.” BMJ 350 (2015). doi: 10.1136/bmj.h2538.

39. Sharon K. Inouye. “Delirium in Older Persons.” N Engl J Med 354(11) (2006): 1157–65. doi: 10.1056/ NEJMra052321.